COVID-19 & Psychiatry: A Retrospective Chart Review

Northwestern University

Status: Active, not recruiting

Conditions: COVID-19

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT05244096

STU00214993

Details and patient eligibility

About

A retrospective chart review study to determine the effects of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression, and severity.

Full description

The goal of this study would be to study the association between use of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression and severity.

Enrollment: 65,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Individuals with a positive COVID-19 test between March 15 2020 to November 30 2021 at Northwestern Medicine hospitals.

Exclusion criteria

Trial design

65,000 participants in 1 patient group

COVID+

Description:

COVID + positive individuals from March 15 2020 to Nov 30, 2021

Treatment:

Other: No intervention